alexa Reduction of ischemic cell death in cultured Islets of Langerhans by the induction of cytoglobin.
Surgery

Surgery

Surgery: Current Research

Author(s): Stagner JI, Seelan RS, Parthasarathy RN, White K

Abstract Share this page

Abstract Despite the source or mechanism of origin of islets of Langerhans or islet β-cells, all suffer significant cell loss from ischemia after isolation, thereby reducing the surviving islet mass available for study or transplantation. Methods to reduce beta cell death after islet isolation and transplantation must be developed if islet transplantation is to become an accepted treatment for diabetes. In order to enhance intracellular oxygen delivery and utilization, islets were transfected with a plasmid encoding cytoglobin, an intracellular oxygen binding protein. Oxygen consumption, insulin secretion, and the degree of central islet necrosis were measured in untreated and transfected islets to test the effects of cytoglobin on islet survival and function in vitro. The presence of cytoglobin reduced islet cell loss by reducing hypoxia related central islet necrosis and increased insulin secretion as compared with untreated islets. Cytoglobin treated islets maintained a normal rate of oxygen consumption, while untreated islets increased the rate of oxygen consumption caused by a shift to anaerobic metabolism and increased reactive oxygen specie synthesis. The induction of cytoglobin in islets may reduce cell loss from chronic hypoxia and may be a useful adjunct to islet transplantation. This article was published in Islets and referenced in Surgery: Current Research

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version